We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
+4.55%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.9B
AUM Growth
+$12.9B
(+136,756%)
Cap. Flow
+$2.44B
Cap. Flow
% of AUM
18.95%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
489
New
192
Increased
92
Reduced
78
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$101M |
| 2 |
Voya Financial
VOYA
|
+$45M |
| 3 |
Arista Networks
ANET
|
+$44.5M |
| 4 |
Atmos Energy
ATO
|
+$41M |
| 5 |
Everest Group
EG
|
+$35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HealthEquity
HQY
|
+$34.8M |
| 2 |
Royal Caribbean
RCL
|
+$33.2M |
| 3 |
Omnicell
OMCL
|
+$29.2M |
| 4 |
Tyler Technologies
TYL
|
+$29.1M |
| 5 |
Cognex
CGNX
|
+$28.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.54% |
| 2 | Technology | 17.46% |
| 3 | Industrials | 16.92% |
| 4 | Consumer Discretionary | 15.93% |
| 5 | Financials | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Tyson Foods
TSN
$20.4B
| $9.76M | 0.08% |
+133,300
| New | +$10.2M |
|
|
GRMN
302
Garmin
GRMN
$56.7B
| $9.74M | 0.08% |
+165,300
| New | +$10.1M |
|
303
Match Group
MTCH
$9.19B
| $9.72M | 0.08% |
+218,750
| New | +$8.46M |
|
304
Paychex
PAYX
$41.6B
| $9.69M | 0.08% |
+157,325
| New | +$10.4M |
|
305
Medtronic
MDT
$109B
| $9.56M | 0.07% |
123,380
-4,895
| -4% | -$404K |
|
306
Hormel Foods
HRL
$13.8B
| $9.53M | 0.07% |
+277,575
| New | +$9.41M |
|
307
Vulcan Materials
VMC
$34.8B
| $9.45M | 0.07% |
+82,750
| New | +$10.4M |
|
308
Polaris
PII
$3.82B
| $9.4M | 0.07% |
+82,125
| New | +$9.88M |
|
309
ICU Medical
ICUI
$4.21B
| $9.34M | 0.07% |
37,017
+34,927
| +1,671% | +$8.21M |
|
310
Cboe Global Markets
CBOE
$32.5B
| $9.22M | 0.07% |
+80,796
| New | +$9.82M |
|
311
Expedia Group
EXPE
$35.4B
| $9.13M | 0.07% |
+82,650
| New | +$9.62M |
|
312
Huntington Ingalls Industries
HII
$12.9B
| $9.11M | 0.07% |
+35,325
| New | +$8.76M |
|
313
Live Nation Entertainment
LYV
$40.6B
| $9.08M | 0.07% |
+215,575
| New | +$9.56M |
|
314
T. Rowe Price
TROW
$23.9B
| $9.06M | 0.07% |
+83,946
| New | +$9.35M |
|
315
Humana
HUM
$43.7B
| $8.97M | 0.07% |
+33,379
| New | +$9.04M |
|
316
Alaska Air
ALK
$5.29B
| $8.95M | 0.07% |
+144,400
| New | +$9.58M |
|
317
Ionis Pharmaceuticals
IONS
$8.6B
| $8.92M | 0.07% |
+202,300
| New | +$10.3M |
|
318
Workday
WDAY
$39.6B
| $8.89M | 0.07% |
+69,925
| New | +$8.55M |
|
319
Lincoln National
LNC
$8.73B
| $8.82M | 0.07% |
+120,775
| New | +$9.47M |
|
320
Lear
LEA
$6.54B
| $8.7M | 0.07% |
+46,775
| New | +$8.81M |
|
|
XLNX
321
DELISTED
Xilinx Inc
XLNX
| $8.5M | 0.07% |
+117,650
| New | +$8.48M |
|
322
Rockwell Automation
ROK
$53.4B
| $8.38M | 0.07% |
+48,100
| New | +$9.13M |
|
323
Clorox
CLX
$11.6B
| $7.95M | 0.06% |
+59,700
| New | +$8.02M |
|
324
Texas Roadhouse
TXRH
$13.5B
| $7.92M | 0.06% |
+137,144
| New | +$7.88M |
|
325
FirstCash
FCFS
$8.85B
| $7.85M | 0.06% |
+97,178
| New | +$7.25M |
|
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q1 2018 Portfolio in Review
As of Q1 2018, Carillon Tower Advisers held 489 positions worth $12.9B, up 136,756% from $9.4M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Carillon Tower Advisers deployed $2.44B of net new capital in Q1 2018, opening 192 new positions and adding to 92 existing holdings. Its largest new stake was Voya Financial: 871,250 shares worth $4.4M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was HealthEquity, an estimated $34.8M trimmed.
- Carillon Tower Advisers's largest Q1 2018 buy was Voya Financial: 871,250 shares worth $4.4M.
- Carillon Tower Advisers added most to DXC Technology in Q1 2018, an estimated $101M increase.
- Carillon Tower Advisers's biggest Q1 2018 reduction was HealthEquity, cutting an estimated $34.8M.
- Carillon Tower Advisers fully exited Prestige Consumer Healthcare in Q1 2018, selling an estimated $404K.
- Carillon Tower Advisers's ten largest holdings make up 13% of its $12.9B portfolio in Q1 2018.
- Carillon Tower Advisers opened 192 new positions and closed 35 in Q1 2018.
- Carillon Tower Advisers's portfolio value rose 136,756% quarter-over-quarter to $12.9B.
Based on Carillon Tower Advisers's 13F filing for Q1 2018, filed 14 May 2018.